Search
for
Sort by
Research 271–300 of 1000+
- Understanding polycystic ovary syndrome
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- [G-proteins, receptor signal transduction, and growth hormone secretion].
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Ethinylestradiol/Chlormadinone Acetate
- Polycystic ovary syndrome in Singapore
- Diagnosis of hyperandrogenism: Biochemical criteria
- Managing polycystic ovary syndrome in primary care
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Polycystic ovary syndrome
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- 9 Role of 5α-reductase in health and disease
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Androgen excess: Investigations and management
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- MENSTRUAL DISORDERS IN ADOLESCENTS
- PCOS in adolescents
- Familial Cortisol Resistance: Differential Diagnostic and Therapeutic Aspects
- Diagnostic criteria for PCOS: Is there a need for a rethink?
- Nonclassic adrenal hyperplasia
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- An Update on Plant Derived Anti-Androgens
- What every physician should know about polycystic ovary syndrome
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- Understanding and Addressing Hair Disorders in Transgender Individuals
- 9 Diagnosis and therapy of hyperandrogenism
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Menopausal Acne – Challenges And Solutions
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men